Neurotechnology Translation Readiness Assessment
Neurotechnology Translation Readiness Assessment
A seven-requirement framework for early assessment of clinical and commercial viability of proposed new neurotechnologies.
If any requirement receives the lowest possible score of 1, eventual success of the overall effort is unlikely. All requirements must be adequately satisfied for success.
Assess the clinical benefit of your neurotechnology compared to current standard of care using the EQ-5D framework.
Complete the questionnaire for both Standard of Care (SoC) and your proposed Neurotechnology solution.
| Category | Standard of Care | Neurotechnology |
|---|---|---|
| Mobility | ||
| Self-Care | ||
| Usual Activities | ||
| Pain/Discomfort | ||
| Anxiety/Depression |
Complete the assessment above
Evaluate whether the incremental cost is justified by the incremental benefit using Cost-Utility Analysis (CUA).
These values are automatically transferred from your Requirement I assessment.
To change HUI values, go back to Requirement I and adjust the EQ-5D assessment/direct HUI entries.
Based on cost-utility analysis quadrant
Assess the degree to which users, caregivers, or the environment experience challenges during setup or operation.
Average of 9 practicality criteria (rounded)
Assess the reliability of the neurotechnology in both short and long term.
Average of 4 reliability criteria (rounded)
Assess the practicality of developing the neurotechnology and introducing it into its intended environment.
Average of 5 ecosystem criteria (rounded)
Assess the challenges associated with obtaining regulatory approval based on precedent.
Based on regulatory precedent
Assess whether there is enough financial incentive to motivate investment in this neurotechnology.
Based on calculated ROI
Not assessed
Not assessed
Not assessed
Not assessed
Not assessed
Not assessed
Not assessed
Download your assessment results for reporting or further analysis.